These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37217811)

  • 1. Multicenter, retrospective registry of isolated atherosclerotic popliteal arteries treated with endovascular revascularization.
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    Heart Vessels; 2023 Sep; 38(9):1117-1129. PubMed ID: 37217811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of the Size of Drug-Coated Balloon Therapy on Restenosis Rate in Femoropopliteal Lesions.
    Kurata N; Iida O; Takahara M; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Hata Y; Mano T
    J Endovasc Ther; 2023 Apr; 30(2):269-280. PubMed ID: 35249409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy.
    Higashino N; Iida O; Ishihara T; Hata Y; Toyoshima T; Tsukizawa T; Nishian K; Fujihara M; Kawasaki D; Mano T
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):1114-1121. PubMed ID: 37855184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different endovascular modalities of treatment for isolated atherosclerotic popliteal artery lesions (EMO-POP) registry.
    Troisi N; Saratzis A; Katsogridakis E; Stavroulakis K; Berchiolli R; Zayed H; Torsello G;
    J Vasc Surg; 2023 Jan; 77(1):231-240.e4. PubMed ID: 35934215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons.
    Yoshioka N; Tokuda T; Koyama A; Yamada T; Nishikawa R; Shimamura K; Takagi K; Morita Y; Tanaka A; Ishii H; Morishima I; Murohara T;
    Heart Vessels; 2022 Apr; 37(4):555-566. PubMed ID: 34553242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year clinical outcomes and predictors of restenosis following the use of polymer-coated paclitaxel-eluting stents or drug-coated balloons in patients with femoropopliteal artery disease.
    Yoshioka N; Tokuda T; Koyama A; Yamada T; Shimamura K; Nishikawa R; Morita Y; Morishima I;
    Heart Vessels; 2023 Mar; 38(3):429-437. PubMed ID: 36169709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenting performs better than drug-coated balloon angioplasty in popliteal lesions.
    Andraska E; Martinez Garcia R; Abdul Malak O; Liang N; Sridharan N; Chaer R; Avgerinos E; Salem K
    J Vasc Surg; 2023 Aug; 78(2):483-489.e1. PubMed ID: 37076110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
    Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
    Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement.
    Nagatomi S; Takahara M; Nakai T; Fujimura N; Yu A; Matsuda D; Yamaoka T; Bolstad F; Yamamoto H; Ichihashi S
    J Vasc Surg; 2023 Jun; 77(6):1751-1759. PubMed ID: 36796593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumen Gain After Endovascular Therapy in Calcified Superficial Femoral Artery Occlusive Disease Assessed by Intravascular Ultrasound (CODE Study).
    Fujihara M; Kozuki A; Tsubakimoto Y; Takahara M; Shintani Y; Fukunaga M; Iwasaki Y; Nakama T; Yokoi Y
    J Endovasc Ther; 2019 Jun; 26(3):322-330. PubMed ID: 30873909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion Characteristics Associated with Loss of Primary Patency After Endovascular Therapy for Common Femoral Artery Lesions.
    Yamauchi Y; Takahara M; Iwata Y; Suzuki K; Fujimura N; Yamaoka T; Miyamoto A; Nakama T;
    Cardiovasc Intervent Radiol; 2023 Mar; 46(3):310-316. PubMed ID: 36627522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Baseline and Postprocedural Intravascular Ultrasound Findings on 1-Year Primary Patency After Drug-Coated Balloon Treatment of Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2022 Feb; 29(1):66-75. PubMed ID: 34781756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Drug-Coated Balloon Versus Drug-Eluting Stent for Native Atherosclerotic Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
    Zenunaj G; Traina L; Acciarri P; Mario Cosacco A; Alesiani F; Baldazzi G; Gasbarro V
    Ann Vasc Surg; 2023 May; 92():294-303. PubMed ID: 36746268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.